Regulatory News

Appointment of joint corporate brokers

RNS Number : 6083K
Darktrace PLC
03 September 2021
 

3 September 2021

Darktrace plc

("the Company")

 

 Appointment of joint corporate brokers

Darktrace plc (DARK.L) (together with its subsidiaries, "Darktrace" or "the Group"), a global leader in cyber security AI, is pleased to announce the appointment of Jefferies and Berenberg as its joint corporate brokers.

 

Poppy Gustafsson, CEO of Darktrace said:

 

"Both Jefferies and Berenberg have been great partners through our successful IPO this year, and we are delighted to continue working with them going forward"

 

Enquiries:

Darktrace

Luk Janssens

+44 7811 027918

[email protected]

 

Powerscourt (PR adviser to Company)

Victoria Palmer-Moore, Elly Williamson

+44 207 549 0745

[email protected]

 

Berenberg

Alex Reynolds, Jen Clarke, Milo Bonser, Arnav Kapoor

+44 203 207 7800

 

Jefferies

Simon Hardy, Will Soutar

+44 207 029 8000 

 

About Darktrace

Darktrace (DARK:L), a global leader in cyber security AI, delivers world-class technology that protects over 5,000 customers worldwide from advanced threats, including ransomware and cloud and SaaS attacks. The company's fundamentally different approach applies Self-Learning AI to enable machines to understand the business in order to autonomously defend it. Headquartered in Cambridge, UK, the company has 1,500 employees and over 30 offices worldwide. Darktrace was named one of TIME magazine's 'Most Influential Companies' for 2021.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPUUVNRAUUKRAR